Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance

Clinical trial NCT06747507 · RECRUITING

Trial details

NCT number: NCT06747507
Sponsor: University of Nairobi
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2025-09-01
Primary completion: 2026-12-01
Enrollment: 392

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.